Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.
about
Remodeling the blood-brain barrier microenvironment by natural products for brain tumor therapy.A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.Crosstalk between M2 macrophages and glioma stem cells.Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors
P2860
Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Dual treatment with shikonin a ...... ial-to-mesenchymal transition.
@en
Dual treatment with shikonin a ...... ial-to-mesenchymal transition.
@nl
type
label
Dual treatment with shikonin a ...... ial-to-mesenchymal transition.
@en
Dual treatment with shikonin a ...... ial-to-mesenchymal transition.
@nl
prefLabel
Dual treatment with shikonin a ...... ial-to-mesenchymal transition.
@en
Dual treatment with shikonin a ...... ial-to-mesenchymal transition.
@nl
P2093
P2860
P50
P1433
P1476
Dual treatment with shikonin a ...... ial-to-mesenchymal transition.
@en
P2093
Bruno Pontes
Joana Balça-Silva
Juliana Echevarria-Lima
Luciane Rosário
Maria Celeste Lopes
Valéria Pereira Ferrer
P2860
P2888
P304
P356
10.1007/S13402-017-0320-1
P577
2017-04-11T00:00:00Z